TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2016 | $260,000 | Replaced |
| 1st Quarter - Amendment | Jun 28, 2016 | $410,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
H.R. 3204: The Drug Quality and Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
Health Issues HCR
H.R. 6: 21st Century Cures/Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELLEY STEWART | — |
Medical/Disease Research/Clinical Labs MED
Zika Virus; Moonshoot Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELLEY STEWART | — |
Medicare/Medicaid MMM
Medicare Part D-activities related to HR 2404/S 1509 (The Treat and Reduce Obesity Act of 2013); Part D Protected classes provision of Affordable Care Act (S648); H.R. 3204: The Drug Quality and Security Act; CMMI Proposed Part B Payment Model; CMS Part B Demo
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| SHELLEY STEWART | — |
| DEBORAH LYNN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.